Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1995;92:2519-2525

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Matsumori, A.
Right arrow Articles by Sasayama, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matsumori, A.
Right arrow Articles by Sasayama, S.

(Circulation. 1995;92:2519-2525.)
© 1995 American Heart Association, Inc.


Articles

Dilated Cardiomyopathy Associated With Hepatitis C Virus Infection

Akira Matsumori, MD; Yoshiki Matoba, MD; Shigetake Sasayama, MD

From the Third Division, Department of Internal Medicine, Faculty of Medicine, Kyoto (Japan) University.

Correspondence to Akira Matsumori, MD, Third Division, Department of Internal Medicine, Faculty of Medicine, Kyoto University, 54 Kawaracho, Shogoin, Sakyo-ku, Kyoto 606, Japan.

Background Myocarditis is thought to be commonly caused by various viruses, and accumulating evidence links viral myocarditis with the eventual development of dilated cardiomyopathy. In many cases, however, the evidence is only circumstantial, and direct conclusive proof is not available. Polymerase chain reaction (PCR) has been used to detect enterovirus RNA in myocardial tissue, but the wide discrepancy in results emphasizes the need for further study.

Methods and Results We investigated hepatitis C virus infection in patients with dilated cardiomyopathy. The presence, type, and quantity of hepatitis C virus RNA were evaluated in the sera, and the presence of positive and negative strands of hepatitis C virus RNA in the heart was investigated with the PCR technique. Anti–hepatitis C virus antibody was present in the sera of 6 of 36 patients (16.7%) with dilated cardiomyopathy and in 1 of 40 patients (2.5%) with ischemic heart disease, showing a statistically significant (P<.05) difference. At an earlier time, acute myocarditis was suspected in 3 patients who had developed acute onset of heart failure, and the diagnosis was confirmed by endomyocardial biopsy in 1 patient. Hepatitis C virus RNA was present in the sera of 4 of the 6 patients, and all 4 had hepatitis C virus type II. The copy number of hepatitis C virus RNA in the serum was 8x102 to 2x103 genomes per 1 mL serum. Positive strands of hepatitis C virus were found in the hearts of 3 patients, and negative strands of hepatitis C virus were detected in the heart of 1 patient.

Conclusions The results suggest that hepatitis C virus infection is frequently found in patients with dilated cardiomyopathy and that hepatitis C virus is an important causal agent in the pathogenesis of the disease. Antiviral therapy against hepatitis C virus may be indicated in these patients.


Key Words: viruses • heart failure • myocarditis • polymerase chain reaction • cardiomyopathy




This article has been cited by other articles:


Home page
CirculationHome page
J. W. Magnani and G. W. Dec
Myocarditis: Current Trends in Diagnosis and Treatment
Circulation, February 14, 2006; 113(6): 876 - 890.
[Full Text] [PDF]


Home page
Circ. Res.Home page
A. Matsumori
Hepatitis C Virus Infection and Cardiomyopathies
Circ. Res., February 4, 2005; 96(2): 144 - 147.
[Full Text] [PDF]


Home page
Circ. Res.Home page
T. Omura, M. Yoshiyama, T. Hayashi, S. Nishiguchi, M. Kaito, S. Horiike, K. Fukuda, S. Inamoto, Y. Kitaura, Y. Nakamura, et al.
Core Protein of Hepatitis C Virus Induces Cardiomyopathy
Circ. Res., February 4, 2005; 96(2): 148 - 150.
[Abstract] [Full Text] [PDF]


Home page
Mayo Clin Proc.Home page
J. J. Ocel, W. D. Edwards, H. D. Tazelaar, L. M. Petrovic, B. S. Edwards, and P. S. Kamath
Heart and Liver Disease in 32 Patients Undergoing Biopsy of Both Organs, With Implications for Heart or Liver Transplantation
Mayo Clin. Proc., April 1, 2004; 79(4): 492 - 501.
[Abstract] [PDF]


Home page
ChestHome page
I. D. Pavord, S. S. Birring, and H. Kanazawa
COPD and Hepatitis C
Chest, November 1, 2003; 124(5): 2035 - 2035.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
F. Calabrese and G. Thiene
Myocarditis and inflammatory cardiomyopathy: microbiological and molecular biological aspects
Cardiovasc Res, October 15, 2003; 60(1): 11 - 25.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
H. Kanazawa, K. Hirata, and J. Yoshikawa
Accelerated Decline of Lung Function in COPD Patients With Chronic Hepatitis C Virus Infection: A Preliminary Study Based on Small Numbers of Patients
Chest, February 1, 2003; 123(2): 596 - 599.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
H. Kanazawa, T. Mamoto, K. Hirata, and J. Yoshikawa
Interferon Therapy Induces the Improvement of Lung Function by Inhaled Corticosteroid Therapy in Asthmatic Patients With Chronic Hepatitis C Virus Infection*: A Preliminary Study
Chest, February 1, 2003; 123(2): 600 - 603.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
A. Frustaci, F. Calabrese, C. Chimenti, M. Pieroni, G. Thiene, and A. Maseri
Lone Hepatitis C Virus Myocarditis Responsive to Immunosuppressive Therapy
Chest, October 1, 2002; 122(4): 1348 - 1356.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. Fujioka, Y. Kitaura, A. Ukimura, H. Deguchi, K. Kawamura, T. Isomura, H. Suma, and A. Shimizu
Evaluation of viral infection in the myocardium of patients with idiopathic dilated cardiomyopathy
J. Am. Coll. Cardiol., November 15, 2000; 36(6): 1920 - 1926.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
A. M. Feldman and D. McNamara
Myocarditis
N. Engl. J. Med., November 9, 2000; 343(19): 1388 - 1398.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Sasayama, A. Matsumori, and Y. Kihara
New insights into the pathophysiological role for cytokines in heart failure
Cardiovasc Res, June 1, 1999; 42(3): 557 - 564.
[Full Text] [PDF]


Home page
CirculationHome page
C. Kawai
From Myocarditis to Cardiomyopathy: Mechanisms of Inflammation and Cell Death : Learning From the Past for the Future
Circulation, March 2, 1999; 99(8): 1091 - 1100.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J.-H. Kao, J.-J. Hwang, M. Okabe, K. Fukuda, K. Arakawa, and M. Kikuchi
Hepatitis C Virus Infection and Chronic Active Myocarditis • Response
Circulation, September 8, 1998; 98(10): 1044 - 1045.
[Full Text]


Home page
HeartHome page
G N Dalekos, K Achenbach, D Christodoulou, G K Liapi, E K Zervou, D A Sideris, and E V Tsianos
Idiopathic dilated cardiomyopathy: lack of association with hepatitis C virus infection
Heart, September 1, 1998; 80(3): 270 - 275.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
H. Hanawa, T. Inomata, Y. Okura, S. Hirono, Y. Ogawa, T. Izumi, M. Kodama, and Y. Aizawa
T Cells With Similar T-Cell Receptor ß-Chain Complementarity-Determining Region 3 Motifs Infiltrate Inflammatory Lesions of Synthetic Peptides Inducing Rat Autoimmune Myocarditis
Circ. Res., July 27, 1998; 83(2): 133 - 140.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Okabe, K. Fukuda, K. Arakawa, and M. Kikuchi
Chronic Variant of Myocarditis Associated With Hepatitis C Virus Infection
Circulation, July 1, 1997; 96(1): 22 - 24.
[Abstract] [Full Text]